Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Grows By 600.7%

CV Sciences, Inc. (OTCMKTS:CVSIGet Free Report) was the recipient of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 44,566 shares, an increase of 600.7% from the February 12th total of 6,360 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 4,555,419 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 4,555,419 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

CV Sciences Stock Performance

Shares of CV Sciences stock traded down $0.01 during trading on Tuesday, hitting $0.05. The stock had a trading volume of 5,340,937 shares, compared to its average volume of 1,255,223. CV Sciences has a 12 month low of $0.02 and a 12 month high of $0.10. The firm’s fifty day simple moving average is $0.05 and its 200-day simple moving average is $0.04. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.21.

CV Sciences Company Profile

(Get Free Report)

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.

Recommended Stories

Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.